Page last updated: 2024-11-05

triazolam and Headache

triazolam has been researched along with Headache in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenblatt, DJ1
Shader, RI1
Divoll, M1
Harmatz, JS1
Olson, KR1
Yin, L1
Osterloh, J1
Tani, A1

Trials

1 trial available for triazolam and Headache

ArticleYear
Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; D

1984

Other Studies

1 other study available for triazolam and Headache

ArticleYear
Coma caused by trivial triazolam overdose.
    The American journal of emergency medicine, 1985, Volume: 3, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Coma; Female; Headache; Humans; Sleep Initiation and Maintenance Disorde

1985